Live feed
Filing
SC 13D/A
SC 13D/A0001214659-21-012525·LA JOLLA PHARMACEUTICAL CO
Schedule 13D ownership disclosure
LA JOLLA PHARMACEUTICAL CO
Security class unavailable · CUSIP: 503459604
Event date: 2021-12-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,607,934
- Percent of class
- 34.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-21-012525
- Form type
- SC 13D/A
- Filer
- LA JOLLA PHARMACEUTICAL CO
- CIK
- CIK 920465
- Filed
- Dec 02, 2021
- Reporting period
- Dec 01, 2021
- Description
- Schedule 13D beneficial ownership